Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Treasury Shares (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Treasury Shares for 2 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • Quarterly Treasury Shares fell 35.49% to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, down 35.49% year-over-year, with the annual reading at $1.6 million for FY2025, 35.49% down from the prior year.
  • Treasury Shares for Q4 2025 was $1.6 million at Pyxis Oncology, down from $1.8 million in the prior quarter.
  • The five-year high for Treasury Shares was $3.1 million in Q1 2024, with the low at $1.6 million in Q4 2025.